General
Join the most exclusive gathering of neuroscience CEOs, investors, pharma decision-makers and innovators in the sector. Three editions in, Bio-Neuroscience has established itself as the event where the most consequential conversations in CNS drug development happen — and where deals begin.
The Premier Gathering — By Design
Bio-Neuroscience is by-invitation in character and strictly limited in size. No filler. No noise. A handpicked assembly of the sector's top CEOs, C-suite executives, managing partners, pharma heads of business development and licensing, and the most active investors in global CNS drug development — convened in a format designed for genuine interaction, not passive attendance.
The Business of Neuroscience Drug Development
This is not a scientific conference or mass access event. It is the exclusive summit where the hottest biotech founders engage the most active neuroscience investors, where pharma business development and therapeutic area heads meet emerging and growth companies, and where the capital markets, M&A, partnering, and strategic questions that shape the sector are discussed in depth. Three days. Sustained working sessions every day. Sustained, high-quality engagement.
A Unique Level of Access — Proven
Bio-Neuroscience 2026 sold out. 2025 firmly established the format. 2024 proved the concept. Participant feedback from every edition confirms what the Advisory Board already knew: there is no comparable event. If you are building, funding, or partnering in CNS neuroscience — this is your room.
Date and Location
Costs and registration
Register here
Contact
Check out the event page for more information!